Mindfulness Meditation Modulates Pain Through Endogenous Opioids Haggai Sharon, MD, Adi Maron-Katz, MSc, Eti Ben Simon, MSc, Yuval Flusser, BA, Talma Hendler, MD, PhD, Ricardo Tarrasch, PhD, Silviu Brill, MD The American Journal of Medicine Volume 129, Issue 7, Pages 755-758 (July 2016) DOI: 10.1016/j.amjmed.2016.03.002 Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure (Top panel) Mean pain and unpleasantness scores. Mean pain (A, left panel) and unpleasantness scores (B, right panel) following: a painful cold stimulus (baseline); natural meditation; meditation after placebo administration; and meditation after naloxone administration, respectively. Bars represent standard error. (Bottom panel) The differences in pain scores following naloxone vs placebo and participants' mindfulness meditation (MM) experience. The positive correlation of the response to intervention with years of experience suggests reduced response to placebo with increasing experience. The American Journal of Medicine 2016 129, 755-758DOI: (10.1016/j.amjmed.2016.03.002) Copyright © 2016 Elsevier Inc. Terms and Conditions